Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-27

Clinical Trial Update: Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Hypericum (St. John's Wort) and Fluoxetine for mild to moderate adolescent depression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)
  • Hypericum (Hypericum perforatum)

Snippet

Sponsor: Rafa Laboratories | Conditions: Depression | Phase 4 | Status: TERMINATED